CNN TürkCHP'de "kurultayı kaçırma" kavgasıPunchUS accuses Minnesota lawmaker-elect’s wife of illegal entrySky TG24Partite Iva e collaboratori, allarme Cgil: in pensione a 71 anni e con assegni bassiInquirerVP trial Day 45: Defense to present DTI, FDA, Citem witnesses on Cale88한겨레Korea’s Democrats move to impeach chief justice of Supreme CourtBollywood HungamaMohitt Maalik to play antagonist opposite Tiger Shroff in spiritual action film VajrThe Hollywood ReporterJennifer Lawrence Thinks Her ‘Hunger Games’ Bow and Arrow Prop Was StolenZDF heuteAktuelle Pressemitteilungen des ZDFAitnewsرسميًا: ChatGPT Health يدعم Health Connect ووكلاء Dots على أندرويد والحاسوبThe South AfricanSouth Africa’s neighbour to import smartphones duty-freeSözcüDünyanın en iyi peyniri bu ülkede üretiliyor: 45 ülkeyi geride bıraktıThe RegisterSupport tech fixed malware by charging client less for their services
The Daily Newsstand · Free, Always
Friday, November 20, 2026

NexgenRx reports Q3 results

Translate
  • NexgenRx press release (NXG:CA): Q3 EBITDA of $1,048,210, representing significant percentage increases of 8%, 48.8% and 18.1%, respectively, compared to the same period in 2025.
  • Revenue of $4.9M.
  • The company recorded a net loss of $63.99K compared to net income of $589.78K in the same period last year.

More on NexgenRx

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.